Toho Pharmaceutical

What Toho Pharmaceutical does

Toho Pharmaceutical Co., Ltd. (東邦薬品株式会社), founded November 2008, is a Japanese pharmaceutical wholesale distributor and the core operating subsidiary of publicly-listed Toho Holdings Co., Ltd. (東邦ホールディングス). Headquartered in Setagaya, Tokyo with approximately 3,024 employees as of March 2026, the company distributes prescription pharmaceuticals, diagnostic reagents, medical devices, and medical materials to hospitals, clinics, and pharmacies across all nine regions of Japan, reaching customers through a national network that includes six regional subsidiaries (Kyushu Toho, Okinawa Toho, Saywell, Koyo, Taishodo, Sky Medical Kyushu) and high-functionality logistics centers — TBC Dynabase (Tokyo, operational since September 2020 with seismic isolation and backup power), TBC Hiroshima, TBC Hanshin, and the planned TBC Tokai (Aichi, completion February 2027, ~¥50B investment, 25,000-item capacity).

The company's product and technology stack centers on proprietary temperature-controlled logistics — Toracool (15–25°C room-temperature vehicle system launching August 2026, co-developed with Wacon), Salmu/Salm (constant-temperature transport without external power), and ATR (blood transport device) — combined with the ENIF customer-support system suite (ENIFweb, ENIFclub, ENIFvoice SP+A, ENIFme, ENIFwin Nex-Sus), the N-Bridge pharmacy DX platform developed with the Japan Pharmaceutical Association and Falmo, the L1MON last-mile patient home-delivery service using Sagawa Express temperature-controlled boxes, and the Doko Shiru elderly protection service adopted by 342 municipalities as of October 2024.

Revenue is generated through three streams: transaction-based pharmaceutical wholesale distribution, recurring subscription fees from IT platform services (prescription transmission, pharmacy management), and managed logistics services including temperature-controlled storage and transport. The go-to-market is sales-led with direct representatives engaging hospitals, clinics, and pharmacies nationwide, supplemented by an integrated channel-partner network of regional subsidiaries. Pricing is contract-based and not publicly disclosed. Recent strategic activity (2024–2026) has focused on intra-group consolidation (absorption mergers with Hokuriku Toho in April 2024, Kyushu Toho/Sky Medical Kyushu in June 2026, and Taishodo in October 2026), strategic partnerships with DHL Supply Chain Japan, T2 (autonomous trucking), Sanofi (BCP), and others, and ongoing automation investments.

Name

Toho Pharmaceutical

Legal name

Toho Pharmaceutical Co., Ltd.

Website

https://tohoyk.co.jp

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1–10 employees

Short description

Toho Pharmaceutical is a Japan-based pharmaceutical wholesaler and core subsidiary of Toho Holdings, distributing prescription drugs, diagnostics, and medical devices to hospitals and pharmacies nationwide through temperature-controlled logistics centers and the ENIF customer-support IT platform.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Warehousing and Storage (493), Refrigerated Warehousing and Storage (493120)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industries

Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD), Pharma & Life Sciences Cold Chain Forwarding (GDP-Compliant) (TLACAMAD), Pharmaceutical & Life Sciences Cold Chain Storage (2–8°C / CRT) (TLALABAF)

Keywords

• Pharmaceutical wholesale
• Medical distribution
• Healthcare logistics
• Pharmacy support systems
• Cold chain transport

Headquarters

HQ city

Setagaya

HQ country

Japan

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Wholesale Distribution: Core revenue from distribution of prescription pharmaceuticals, diagnostic reagents, medical devices, and medical materials to healthcare institutions and pharmacies
2. Customer Support System Services: IT platform services including prescription transmission systems, pharmacy management systems, and medical institution support tools
3. Logistics Services: Specialized pharmaceutical logistics including temperature-controlled storage and transport, cold chain management

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Toho Pharmaceutical is a pharmaceutical wholesaler that distributes prescription drugs, diagnostic reagents, medical devices, and medical materials to hospitals, clinics, and pharmacies across Japan. It complements physical distribution with a proprietary ENIF customer support IT platform suite for prescription transmission, pharmacy management, ordering, and inventory. It also provides specialized temperature-controlled transport devices and services (Toracool vehicles, Salm containers, ATR blood transport) and operates high-functionality logistics centers including the disaster-resilient TBC Dynabase.

Product overview

Toho Pharmaceutical operates as a pharmaceutical wholesale company offering a platform-plus-modules architecture centered on customer support systems for medical institutions and pharmacies. The core product portfolio includes: (1) telemedicine platforms like KAITOS and LXMATE HeLios cloud; (2) pharmacy management systems including ・ミザル (Mizaru), Core-POS, and ENIF series systems; (3) prescription transmission systems like ENI Pharmacy and NB Station within the N-Bridge DX platform; (4) medical material sales platforms such as ENIFme and ENIFclub; (5) temperature-controlled transport solutions including サルム (Salmu), トラクール (Toracool), and ATR blood transport devices; (6) elderly protection services like どこシル伝言板; and (7) specialty product home delivery service L1MON. These systems are interconnected through web-based platforms like FutureENIF-WEB and e-ENIF, enabling medical institutions, pharmacies, and patients to access pharmaceutical products, medical information, and healthcare services through a unified logistics and information network.

Differentiator

Problem solved

Functional benefit

Brands

• TBC Dynabase (TBCダイナベース): High-functionality logistics center in Tokyo Metropolitan area with advanced robotics and automation for pharmaceutical logistics, also serves as disaster response base for Tokyo
• Tracool (トラクール)
• Salmu (サルム)
• ATR (血液죵반装置 ATR)
• Docoshiru Message Board (どこシル伝言板)
• KAITOS (カイトス)
• ENIF Series (ENIFシリーズ)
• L1MON (リムオン)
• FutureENIF-WEB (共創未来ポータル)
• LXMATE HeLios cloud
• Mizaru (ミザル)
• Byoin Navi (病院なび)

Products and services

• KAITOS Online medical consultation and medication guidance system enabling remote healthcare services between medical institutions and patients.
• LXMATE HeLios cloud Cloud-based medical appointment and first-visit reception system for medical institutions.
• Mizaru (ミザル) Pharmacy headquarters system for managing dispensing operations, inventory, and patient services for pharmacy chains.
• ENIFclub Medical material split sales and product sharing system for ENIFclub members and medical institutions needing to procure small-lot medical materials.
• ENIFwin Nex-Sus Wholesale ordering and inventory management system for pharmacies and medical institutions.
• ENI Pharmacy (ENIファーマシー)

Quantifiable outcome

• 342 municipalities deployed with dementia elderly protection service as of October 2024
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature4 records

Partnerships

Twelve partnerships are on record, tiered core, major and minor.

• DHL Supply Chain Japan (DHLサプライチェーンジャパン株式会社)coreStrategic or Co-development Partner · 4 June 2026Partnership for comprehensive logistics solutions in Japan, aiming to build advanced healthcare logistics platform by combining DHL's global logistics network with Toho's pharmaceutical distribution network. Focus on manufacturer logistics, clinical trial logistics, and one-stop pharmaceutical distribution services.
• Kyowa Medical Instruments (協和医科器械株式会社)majorStrategic or Co-development Partner · 14 May 2026Joint research partnership to strengthen SPD functions in Tokai region by combining Kyowa's medical material SPD capabilities with Toho's pharmaceutical SPD expertise for next-generation healthcare solutions.
• Collabo Create (株式会社コラボクリエスト)majorStrategic or Co-development Partner · 25 March 2026Participation in joint venture for social issue-responsive healthcare logistics, combining assets and expertise across multiple companies including Toho Holdings, Suzuki, Mitsui Soko, Seino Holdings, and others.
• Sanofi (サノフィ株式会社)coreStrategic or Co-development Partner · 28 January 2026BCP collaboration for pharmaceutical supply during disasters, including successful demonstration of Shinkansen transport for insulin products during disaster scenarios.
• Japan Pharmaceutical Association (公益社団法人日本医師会)coreStrategic or Co-development Partner · 8 October 2025Collaboration for N-Bridge pharmacy DX foundation service development, with ENIF Pharmacy system serving as core technology for NB Station prescription transmission terminal.
• Blue Innovation (ブルーイノベーション株式会社)majorStrategic or Co-development Partner · 25 September 2025Strategic partnership for drone and robot DX solutions for pharmaceutical logistics during normal times and disaster scenarios.
• Teijin Lignet (帝人リジェネット株式会社) and Itochu (伊藤忠商事株式会社)majorStrategic or Co-development Partner · 10 July 2025Regenerative medicine ecosystem partnership for supporting biotech venture product launches through integrated manufacturing, logistics, and material procurement services.
• Farmu (株式会社ファルモ)coreStrategic or Co-development Partner · 1 June 2025Capital and business partnership for pharmacy ICT services, including joint development of electronic medication record Kyoso Mirai Pharmacy Kenko Navi, and Every series product distribution.
• Kyoso Mirai Pharma (共創未来ファーマ株式会社)coreStrategic or Co-development Partner · 27 March 2025Subsidiary partnership for Haneda Packaging Center co-location with TBC Dynabase, enabling one-stop supply chain from manufacturing to wholesale distribution.
• T2 (株式会社T2)coreStrategic or Co-development Partner · 21 January 2025Strategic partnership for autonomous driving truck research and development in pharmaceutical distribution. T2 plans Level 4 autonomous truck干线輸送 service launch in 2027, with joint verification experiments using TBC Dynabase to TBC Hanshin route.
• Japan Ground Self-Defense ForceminorOthers · 26 September 2024Joint disaster response training for pharmaceutical supply during emergencies, including supply of medical supplies to Self-Defense Force units.
• Wakon (ワコン株式会社)coreTechnology or Integration · 25 September 2024Capital and business partnership for temperature-controlled storage and transport technology development. Developed Toracool temperature-controlled vehicle system and temperature-managed roll box pallets.

Scale indicators6 records

Recent moves12 records

Expansion highlights6 records

Others

• DHL Supply Chain Japan: Global contract logistics provider and Toho Pharmaceutical's strategic partner (Jun 2026) for clinical trial and manufacturer logistics in Japan; adjacent infrastructure partner rather than a wholesaler competitor.
• Kyoso Mirai Pharma Co., Ltd. Toho Holdings subsidiary operating pharmaceutical manufacturing and a packaging center co-located with TBC Dynabase; adjacent in-group participant rather than an external competitor.

Broad incumbents

• Toho Holdings Co., Ltd. Publicly-listed parent of Toho Pharmaceutical, operating a diversified pharmaceutical distribution and manufacturing conglomerate across Japan; Toho Pharmaceutical is the core wholesale subsidiary within a broader multi-subsidiary group.
• Cardinal Health: Global pharmaceutical wholesale and medical product distribution incumbent; benchmark for Toho on B2B pharma distribution scale, customer support IT, and healthcare supply chain economics.
• McKesson Corporation: Global pharmaceutical distribution and healthcare services incumbent; relevant global comparable for Toho's distribution-plus-IT-platform model, though at vastly larger scale and with US/Europe focus.

Direct peers

• Alfresa Corporation: Japan's largest pharmaceutical wholesaler distributing prescription drugs, diagnostics, and medical devices nationwide; directly competes with Toho Pharmaceutical for hospital and pharmacy accounts across the same Big-4 oligopoly structure.
• Mediceo Corporation: Wholly-owned Medipal subsidiary and one of Japan's Big-4 pharmaceutical wholesalers; competes with Toho Pharmaceutical on prescription drug distribution nationwide with similar manufacturer rebate and logistics economics.
• Suzuken Co., Ltd. One of Japan's Big-4 pharmaceutical wholesalers operating centralized distribution centers and medical IT platforms; directly comparable to Toho on customer base (hospitals/pharmacies) and product breadth.
• Medipal Holdings: Major Japanese pharmaceutical wholesaler group (parent of Mediceo Corporation); competes head-to-head with Toho for nationwide prescription distribution, with comparable temperature-controlled logistics and manufacturer partnerships.

Emerging players

• T2 Corporation: Japanese autonomous driving truck venture that partnered with Toho Pharmaceutical (Jan 2025) for Level-4 autonomous inter-logistics-center trucking by 2027; relevant as a fellow emerging player in pharma logistics technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/touhouyakuhin12

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Toho Pharmaceutical